MRD results directly impact treatment decisions in CML thus it is very important that the accuracy and precision of BCR::ABL1 assays are maintained across the entire measurement range, and that the sensitivity of the test is sufficient to measure DMR. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.